MEMANTINE CRISTERS 10 mg, film-coated tablet scored 56 tablets
Active ingredients: Memantine hydrochloride, Memantine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MEMANTINE CRISTERS 10 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 56 comprimé(s)
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 16 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60288443CIP72750484CIP133400927504846Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE MÉMANTINEcomprimé | 10 mg · un comprimé | SA |
| MÉMANTINE BASEcomprimé | 8,31 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.